活体供肾移植中基于低剂量他克莫司（FK 506）的免疫抑制方案 - Suppr

Suppr

超能文献

Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.

作者信息

Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang J D, Okuyama A

机构信息

Department of Urology, Osaka University Medical School, Japan.

出版信息

Transplant Proc. 1999 Feb-Mar;31(1-2):1151-4. doi: 10.1016/s0041-1345(98)01942-3.

DOI:10.1016/s0041-1345(98)01942-3

PMID:10083515

Abstract

摘要

相似文献

Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.

Transplant Proc. 1999 Feb-Mar;31(1-2):1151-4. doi: 10.1016/s0041-1345(98)01942-3.

Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.

Transplant Proc. 2000 Nov;32(7):1733-5. doi: 10.1016/s0041-1345(00)01396-8.

FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):304-5. doi: 10.1016/s0041-1345(96)00270-9.

Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.

Transplant Proc. 1996 Apr;28(2):998-9.

Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.

Transplant Proc. 1996 Feb;28(1):400-1.

Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.

Transplant Proc. 1999 Nov;31(7A):37S-40S. doi: 10.1016/s0041-1345(99)00792-7.

Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.

Transplant Proc. 2000 Nov;32(7):1726-9. doi: 10.1016/s0041-1345(00)01398-1.

Evaluation of various immunosuppressive regimes in second renal transplants.

Transplant Proc. 2001 May;33(3):2315-6. doi: 10.1016/s0041-1345(01)02005-x.

FK506 for primary and rescue therapy following liver transplantation.

Transplant Proc. 1998 Jun;30(4):1409-10. doi: 10.1016/s0041-1345(98)00293-0.

ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.

Transplant Proc. 1997 Nov;29(7):2805-6. doi: 10.1016/s0041-1345(97)00686-6.

引用本文的文献

Reversibility of tacrolimus-induced alopecia : a case report and literature review.

Clin Drug Investig. 2003;23(9):611-4. doi: 10.2165/00044011-200323090-00008.

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.

作者信息

Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang J D, Okuyama A

机构信息

Department of Urology, Osaka University Medical School, Japan.

出版信息

Transplant Proc. 1999 Feb-Mar;31(1-2):1151-4. doi: 10.1016/s0041-1345(98)01942-3.

DOI:10.1016/s0041-1345(98)01942-3

PMID:10083515

Abstract

摘要

相似文献

Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.

Transplant Proc. 1999 Feb-Mar;31(1-2):1151-4. doi: 10.1016/s0041-1345(98)01942-3.

Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.

Transplant Proc. 2000 Nov;32(7):1733-5. doi: 10.1016/s0041-1345(00)01396-8.

FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):304-5. doi: 10.1016/s0041-1345(96)00270-9.

Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.

Transplant Proc. 1996 Apr;28(2):998-9.

Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.

Transplant Proc. 1996 Feb;28(1):400-1.

Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.

Transplant Proc. 1999 Nov;31(7A):37S-40S. doi: 10.1016/s0041-1345(99)00792-7.

Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.

Transplant Proc. 2000 Nov;32(7):1726-9. doi: 10.1016/s0041-1345(00)01398-1.

Evaluation of various immunosuppressive regimes in second renal transplants.

Transplant Proc. 2001 May;33(3):2315-6. doi: 10.1016/s0041-1345(01)02005-x.

FK506 for primary and rescue therapy following liver transplantation.

Transplant Proc. 1998 Jun;30(4):1409-10. doi: 10.1016/s0041-1345(98)00293-0.

ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.

Transplant Proc. 1997 Nov;29(7):2805-6. doi: 10.1016/s0041-1345(97)00686-6.

引用本文的文献

Reversibility of tacrolimus-induced alopecia : a case report and literature review.

Clin Drug Investig. 2003;23(9):611-4. doi: 10.2165/00044011-200323090-00008.

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.